Ipsen S.A. publishes its 2024 consolidated financial statements
- 21 February 2025 - 1 mins read
Ipsen S.A. – 2024 Consolidated Financial Statements
Attachment
19 March 2025
7 mins read
Ipsen announces issuance of €500 million inaugural Rated Public Bond
06 March 2025
1 mins read
Ipsen – February 2025 – Monthly information relative to the total number of voting rights and shares composing the share capital
06 February 2025
1 mins read
Ipsen – January 2025 – Monthly information relative to the total number of voting rights and shares composing the share capital
07 January 2025
1 mins read
Ipsen – Half year statement – 2024 12 31
07 January 2025
1 mins read
Ipsen – December 2024 – Monthly information relative to the total number of voting rights and shares composing the share capital
09 December 2024
1 mins read
Ipsen – November 2024 – Monthly information relative to the total number of voting rights and shares composing the share capital
07 November 2024
1 mins read
Ipsen – October 2024 – Monthly information relative to the total number of voting rights and shares composing the share capital
09 October 2024
1 mins read
Ipsen – September 2024 – Monthly information relative to the total number of voting rights and shares composing the share capital
18 September 2024
9 mins read
Final results from CABINET Phase III trial reinforce efficacy benefits of Cabometyx® in advanced neuroendocrine tumors
16 September 2024
9 mins read